No Evidence of Disease
14
0
1
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
2 terminated out of 14 trials
83.3%
-3.2% vs benchmark
14%
2 trials in Phase 3/4
30%
3 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (14)
Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission
Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
Biomarkers in Post-Menopausal Women Receiving Flaxseed
Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
Oxybutynin Chloride in Managing Hot Flashes
Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening
Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers
Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers
Study of 9cUAB30 in Healthy Participants
Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants